ArticleJournal for immunotherapy of cancer2022

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.

Joan Frigola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.